Mood stabilizers: protecting the mood…protecting the brain
- 30 April 2004
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 79, 15-20
- https://doi.org/10.1016/j.jad.2004.01.002
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- In Vivo Evidence in the Brain for Lithium Inhibition of Glycogen Synthase Kinase-3Neuropsychopharmacology, 2003
- Search for a common mechanism of mood stabilizersBiochemical Pharmacology, 2003
- Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic–depressive illnessBiological Psychiatry, 2000
- The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3Journal of Neurochemistry, 2000
- Abnormalities of cAMP signaling in affective disorders: implications for pathophysiology and treatmentBipolar Disorders, 2000
- Regulation of Signal Transduction Pathways and Gene Expression by Mood Stabilizers and AntidepressantsPsychosomatic Medicine, 1999
- Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cellsMolecular Brain Research, 1998
- Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cellsCurrent Biology, 1996
- Enhanced protein kinase C activity and translocation in bipolar affective disorder brainsBiological Psychiatry, 1996
- Chronic Sodium Valproate Selectively Decreases Protein Kinase C α and ε In VitroJournal of Neurochemistry, 1994